Neuronetics, Inc.
STIM
Positions held
Your positionsSTIM isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $163.06M | Enterprise value | $234.18M | Trailing P/E | — | Forward P/E | -6.29 |
| PEG | — | Price / book | 9.15 | Beta | 1.20 | Dividend yield | 0.00% |
| Revenue growth | 9.1% | Earnings growth | — | Gross margin | 49.4% | Operating margin | -3.6% |
| Profit margin | -19.6% | ROE | -116.1% | ROA | -10.5% | Debt / equity | 4.00 |
| Current ratio | 1.88 | Free cash flow | $345,625 | Analyst recommendation | strong_buy | Mean target | $5.75 |
| 52w high | $3.44 | 52w low | $0.80 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $41.6M | $34.5M | $41.8M | $37.3M | $38.1M |
| Op margin | -3.6% | -26.1% | -12.1% | -19.6% | -21.1% |
| Net income | -$3.4M | -$10.8M | -$7.2M | -$9.0M | -$10.1M |
| Gross margin | 51.1% | 46.9% | 52.0% | 45.9% | 46.6% |
| Gross profit | $21.2M | $16.2M | $21.7M | $17.1M | $17.8M |
| Operating income | -$1.5M | -$9.0M | -$5.0M | -$7.3M | -$8.1M |
- Revenue +21% vs prior quarter ($42M vs $34M).
- Gross margin 51% (was 46.9% prior quarter).
- Operating margin expanded to -3.6%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $149M | $74.9M | $71.3M | $65.2M |
| Op margin | -21.1% | -46.2% | -42.8% | -53.8% |
| Net income | -$39.0M | -$43.7M | -$30.2M | -$37.2M |
| Gross margin | 48.5% | 72.3% | 72.5% | 76.3% |
| Gross profit | $72.3M | $54.2M | $51.7M | $49.7M |
| Operating income | -$31.4M | -$34.6M | -$30.6M | -$35.1M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-08 · NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System
2026-08-18 · Neuronetics (STIM) Q2 2026 Earnings Call Transcript
2026-08-12 · Neuronetics, Inc. Q2 2026 Earnings Call Summary
2026-08-11 · Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ...
2026-08-11 · Neuronetics Q2 Earnings Call Highlights
2026-08-11 · Neuronetics Narrows Q2 Loss as Greenbrook Growth Drives 9% Revenue Increase
2026-08-11 · Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates
2026-08-11 · Neuronetics: Q2 Earnings Snapshot
2026-08-11 · Neuronetics Reports Second Quarter 2026 Financial and Operating Results
2026-08-06 · Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates
2026-08-03 · Neuronetics and Jorey Chernett Announce Shared Vision
2026-07-31 · Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Price (daily)
Full chart · RSI · MACD · patterns